Inventor · disambiguated record
Saraswati Sukumar
Also filed as: SUKUMAR SARASWATI · SUKUMAR SARASWATI V · SUKUMAR SARASWATI VAIDYANATHAN
20 granted patents·13 pending applications·372 citations·filing 1996–2021
95Inventor score
Files withUNIV JOHNS HOPKINS13UNIV JOHNS HOPKINS MED10SUKUMAR SARASWATI5GENZYME CORP2SUKUMAR SARASWATI V2
Top patents by PatentIndex Score
33 records- 0195US8822155B2Quantitative multiplex methylation-specific PCRSUKUMAR SARASWATI·Filed 2011·Granted Sep 2, 2014·258 cites·21 claims
- 0294US7196070B2Prophylactic and therapeutic treatment of the ductal epithelium of a mammary gland for cancerUNIV JOHNS HOPKINS MED·Filed 2005·Granted Mar 27, 2007·10 cites·12 claims
- 0386US9416404B2Quantitative multiplex methylation-specific PCRUNIV JOHNS HOPKINS·Filed 2014·Granted Aug 16, 2016·4 cites·3 claims
- 0483US10450609B2Quantitative multiplex methylation specific PCR method—cMethDNA, reagents, and its useUNIV JOHNS HOPKINS·Filed 2013·Granted Oct 22, 2019·6 cites·11 claims
- 0583US8062849B2Quantitative multiplex methylation-specific PCRSUKUMAR SARASWATI·Filed 2004·Granted Nov 22, 2011·14 cites·43 claims
- 0683US7858317B2Aberrantly methylated genes as markers of breast malignancyUNIV JOHNS HOPKINS MED·Filed 2008·Granted Dec 28, 2010·3 cites·16 claims
- 0783US6559130B1Destruction of the epithelium of an exocrine gland in the prophylactic and therapeutic treatment of cancerUNIV JOHNS HOPKINS MED·Filed 2000·Granted May 6, 2003·8 cites·21 claims
- 0883US5763415ADestruction of the epithelium of an exocrine gland in the prophylactic and therapeutic treatment of cancerUNIV JOHNS HOPKINS·Filed 1996·Granted Jun 9, 1998·39 cites·1 claims
- 0982US6756200B2Aberrantly methylated genes as markers of breast malignancyUNIV JOHNS HOPKINS MED·Filed 2001·Granted Jun 29, 2004·12 cites·18 claims
- 1077US6835541B2Aberrantly methylated genes as markers of breast malignancyUNIV JOHNS HOPKINS MED·Filed 2002·Granted Dec 28, 2004·5 cites·22 claims
- 1174US6656918B2Prophylactic and therapeutic treatment of the ductal epithelium of a mammary gland for cancerUNIV JOHNS HOPKINS MED·Filed 2000·Granted Dec 2, 2003·2 cites·14 claims
- 1273US2009117038A1Breast Endothelial Cell Expression PatternsGENZYME CORP·Filed 2008·Application pending·0 cites
- 1372US6932777B2Prophylactic and therapeutic treatment of the ductal epithelium of a mammary gland for cancerUNIV JOHNS HOPKINS MED·Filed 2001·Granted Aug 23, 2005·1 cites·17 claims
- 1468US2014056911A1Breast Endothelial Cell Expression PatternsGENZYME CORP·Filed 2013·Application pending·0 cites
- 1567US10316361B2Genome-wide methylation analysis and use to identify genes specific to breast cancer hormone receptor status and risk of recurrenceSUKUMAR SARASWATI V·Filed 2012·Granted Jun 11, 2019·1 cites·10 claims
- 1665US12448650B2Quantitative multiplex methylation specific PCR method-CMethDNA, reagents, and its useUNIV JOHNS HOPKINS·Filed 2019·Granted Oct 21, 2025·0 cites·8 claims
- 1764US2005191640A1Aberrantly methylated genes as markers of breast malignancyUNIV JOHNS HOPKINS MED·Filed 2004·Application pending·0 cites
- 1864US2007178090A1Breast endothelial cell expression patternsUNIV JOHNS HOPKINS·Filed 2004·Application pending·0 cites
- 1964US2006292113A1Prophylactic and therapeutic treatment of the ductal epithelium of a mammary gland for cancerUNIV JOHNS HOPKINS MED·Filed 2006·Application pending·0 cites
- 2060US2015315269A1Breast Endothelial Cell Expression PatternsUNIV JOHNS HOPKINS·Filed 2015·Application pending·0 cites
- 2158US8093013B2Claudins as markers for early detection, diagnosis, prognosis and as targets of therapy for breast and metastatic brain or bone cancerSUKUMAR SARASWATI V·Filed 2008·Granted Jan 10, 2012·0 cites·3 claims
- 2256US9540694B2HEYL as a therapeutic target and a diagnostic marker for neoplasia and uses thereforSUKUMAR SARASWATI·Filed 2007·Granted Jan 10, 2017·1 cites·6 claims
- 2356US8568985B2Breast endothelial cell expression patternsSUKUMAR SARASWATI·Filed 2011·Granted Oct 29, 2013·0 cites·13 claims
- 2456US2023160018A1Crybetab2 predicts poor breast cancer outcome and sensitizes tumors to nucleolin and cdk inhibitionUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 2554US6330472B2Prophylactic and therapeutic treatment of the ductal epithelium for a mammary gland for cancerUNIV JOHNS HOPKINS MED·Filed 1999·Granted Dec 11, 2001·5 cites·18 claims
- 2650US2024279740A1Methylated markers for accurate detection of primary central nervous system and systemic diffuse large b cell lymphomaUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 2748US2022364177A1Dna markers for differentiation of biopsy samplesUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
- 2843US2010285031A1Hox Compositions and MethodsUNIV JOHNS HOPKINS·Filed 2007·Application pending·0 cites
- 2942US6153184ADestruction of the epithelium of an exocrine gland in the prophylactic and therapeutic treatment of cancerUNIV JOHNS HOPKINS·Filed 1998·Granted Nov 28, 2000·3 cites·31 claims
- 3041US2009227692A1Biomarkers for breast cancerUNIV JOHNS HOPKINS·Filed 2006·Application pending·0 cites
- 3140US2005074798A1Claudins as markers for early detection, diagnosis, prognosis and as targets of therapy for breast and metastatic brain or bone cancerFiled 2004·Application pending·0 cites
- 3238US2013333059A1Hox compositions and methodsUNIV JOHNS HOPKINS·Filed 2012·Application pending·0 cites
- 3334US9062308B2Compositions and methods for treatment of tamoxifen resistant breast cancerSUKUMAR SARASWATI·Filed 2012·Granted Jun 23, 2015·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Saraswati Sukumar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →